Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch
Condition(s):Bioequivalence – Irritation and Sensitization Potential of Transdermal PatchLast Updated:April 4, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Bioequivalence – Irritation and Sensitization Potential of Transdermal PatchLast Updated:April 4, 2016Completed
Condition(s):Dry EyeLast Updated:December 9, 2013Completed
Condition(s):Second Hand Tobacco SmokeLast Updated:June 14, 2021Completed
Condition(s):Safety IssuesLast Updated:January 11, 2021Completed
Condition(s):Dry EyeLast Updated:July 2, 2017Completed
Condition(s):Allergic RhinoconjunctivitisLast Updated:January 19, 2017Completed
Condition(s):Allergic Rhinoconjunctivitis; Healthy VolunteersLast Updated:January 17, 2018Terminated
Condition(s):Allergic Rhino-ConjunctivitisLast Updated:December 3, 2015Completed
Condition(s):SmokingLast Updated:April 10, 2018Completed
Condition(s):Allergic RhinitisLast Updated:March 3, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.